A targeted therapy for melanoma by graphene oxide composite with microRNA carrier

Shijie Tang,Can Liu,Xiaoqing Chen,Jianda Zhou,Lichun Sun,Xiangyan Zhang,Defei Peng,Xiang Chen,Jin-ming Yu,H. Xie
DOI: https://doi.org/10.2147/DDDT.S160088
2018-09-01
Abstract:Background Nowadays, the combination of microRNA (miR) is attracting increased attention in clinical cancer trials. However, the clinical use of miR is highly limited because of certain properties such as instability, low-specificity distribution, and metabolic toxicity. Methods In order to improve the anti-tumor efficacy and reduce the side effects of miR in treating melanoma, a combination of graphene oxide (GO), chitosan (CS), and a cellular penetrating peptide, MPG, was prepared with solid dispersion method in this research. The research has analyzed the specific components of nano drug-loading complexes GO-CS and GO-CS-MPG through characterization research and confirmed the bio-safety of the carrier material GO-CS-MPG. Results The GO-CS-MPG-miR33a/miR199a nano drug-loading complex was successfully constructed and its medical effectiveness was verified. Through the subcutaneous tumor implantation experiment, an evident effect of the drug-loading complex in inhibiting melanoma cells was proven. Conclusion Results suggest that GO-CS-MPG may have potential applications in melanoma therapy.
Chemistry,Medicine,Materials Science
What problem does this paper attempt to address?